Navigation Links
Danger From Heart Surgery Drug Confirmed
Date:5/14/2008

Data on increased death risk should permanently end use of Trasylol, experts say

WEDNESDAY, May 14 (HealthDay News) -- A new Canadian study confirms that people given Trasylol, a drug used to reduce bleeding during heart surgery, increases their risk of death by 53 percent.

Trasylol's German maker, Bayer AG, suspended marketing in the United States last November after preliminary results from this trial revealed problems with the medication.

"In the trial, we asked whether apportioning [Trasylol] was more effective at reducing massive bleeding during high-risk heart surgery compared to other drugs," lead investigator Dr. Dean A. Fergusson, from the University of Ottawa Centre for Transfusion Research, said during a teleconference Monday.

"We also asked were serious complications, such as death and organ failure, lower for aprotinin compared to the two other drugs," Fergusson said.

The report was published in the May 13 online issue of the New England Journal of Medicine.

In the Canadian trial, known as BART, Trasylol was compared with two similar drugs Cyklokapron (tranexamic acid) and Amicar (aminocaproic acid).

During the trial, 2,331 high-risk cardiac patients undergoing heart surgery were randomly assigned to one of the three drugs.

"The most important outcome of the trial was a bit of surprise," co-principal investigator Dr. Paul C. Hebert, a critical care physician at Ottawa Hospital, said during Monday's teleconference.

The rate of death from Trasylol was 6 percent versus 3.9 percent and 4 percent for the other two drugs, Hebert said. "This represents a 53 percent of relative risk of dying, which translates into for every 50 patients treated with apportioning, one patient would die," he said.

Most of the deaths associated with Trasylol were from cardiac complications, Hebert said. Because of the significant increased risk of death, the trial
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Dr. Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers
2. Mothers Pass Dangerous Toxins to Babies Through Breast Milk
3. Psoriasis Poses Danger for More Serious Complications
4. American Lung Association Applauds Energy and Commerce Committee for its Strong Commitment to Protecting Public Health From the Dangers of Tobacco
5. Lung transplants not dangerous for children with cystic fibrosis, after all
6. How dangerous is boxing for the brain?
7. Fort Dodges Mosquito Shot Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses
8. The price paid for higher energy is highly dangerous to teeth
9. LightAir Cleans the Air From the Smallest and Most Dangerous Particles Without Generating Ozone
10. Poor sleep more dangerous for women
11. New Drug for Brain Cancer Too Dangerous for Pediatric Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Danger From Heart Surgery Drug Confirmed
(Date:11/22/2014)... 23, 2014 BambooFlooringChina.com is a ... has proudly released its new collection of bamboo mats ... up to 29% off. , According to the ... tree-like grass, making it a highly renewable resource. Their bamboo ... a mixing color which comes from natural bamboo with caramel ...
(Date:11/22/2014)... Setria® Glutathione is now available ... for use “as a therapeutically active ingredient in ... Therapeutic Goods (Listing) Notice 2014 (No. 5) - ... Glutathione will be exclusivity distributed in Australia by ... imports fine chemicals to Australian manufacturers. TGA approval ...
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... November 22, 2014 Nocturia is ... the complaint that the individual has to wake ... The report “Nocturia – Pipeline Review, H2 2014” ... Nocturia, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:11/22/2014)... 22, 2014 A petition seeking a ... ) in minimally-invasive hysterectomies and fibroid removal surgeries ... end of October, Bernstein Liebhard LLP reports. According ... of November 21st, 2014. That represents an increase of ... signed on to the campaign.* , The campaign to ...
Breaking Medicine News(10 mins):Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4
... ... and navigation enhancement XML API. , ... (PRWEB) May 27, 2010 -- Smartlogic has released a ... websites or in enterprise information management systems, using Semaphore,s search and navigation enhancement XML ...
... Helicobacter pylori , which lives in the human stomach ... like a corkscrew, or helix. For years researchers have hypothesized ... survive and thrive within the stomach,s acid-drenched environment, ... the first time, researchers at Fred Hutchinson Cancer Research Center ...
... Schrader had it all: steady job, a wife, and two ... morethat is, more children. Taking steps to keep his nuclear ... was back on the golf course the next afternoon. ... that followed Schrader would ultimately revisit the issue of having ...
... mood of those with sensitivities worsened when exposed to ... season may not mean just the inevitable coughing, sneezing ... , Researchers reported that finding at the American Psychiatric ... "Depression is a very common disorder and allergies are ...
... , ... announced that they have now added 7,000 stores in under five months of operation. The ... 100-200 new comments per day and 500 votes per day, making it one of the ... ...
... tying genes to common tumors may be invalid, researchers ... sample sizes may undercut the reliability of recent genome ... a Greek-American analysis cautions. , The observation is the ... harnessed technological innovations in so-called "whole genome sequencing" to ...
Cached Medicine News:Health News:Smartlogic Demonstrates Improved User Search, Find and Navigation with Semaphore Open Semantic Platform 2Health News:Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach 2Health News:Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach 3Health News:Robotic-assisted vasectomy reversal offers greater chance of fatherhood 2Health News:Allergies Might Trigger Depression 2Health News:Coupon Site TrimBack.com Adds 7000th Online Store 2Health News:Genes' Link to Certain Cancers Questioned 2
(Date:11/22/2014)... , Nov. 21, 2014 Research and Markets ... Protein Drug Industry Report, 2014-2017" report to their ... The Chinese recombinant protein drug market has been ... consumption ability and the like. During 2005-2013, sales of ... at a CAGR of 19.1%, and it is projected ...
(Date:11/21/2014)... -- Alere Inc. (NYSE: ALR ), a global ... Cunningham as Vice President, Investor Relations. In this ... communications with the investment community. "As we ... increase shareholder value, it is critical that we effectively ... Executive Officer. "We are delighted that Juliet Cunningham ...
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2
... 2010 Abaxis, Inc. (Nasdaq: ABAX ), ... today announced the release of a new Piccolo® reagent ... disc will be used by healthcare professionals in conjunction ... of this new panel configuration, U.S. healthcare professionals can ...
... 12, 2010 EntreMed, Inc. (Nasdaq: ... for the treatment of cancer, today reported results ... 30, 2010. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO) ... net loss for the third quarter of 2010 ...
Cached Medicine Technology:Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus 2Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus 3EntreMed Reports Third Quarter 2010 Financial Results 2EntreMed Reports Third Quarter 2010 Financial Results 3EntreMed Reports Third Quarter 2010 Financial Results 4
Female Mini-VEST Seamless, Front Closure...
Male Support Brief...
For Lipoplasty or surgery of abdomen, flanks and midriff...
Select Support Brief...
Medicine Products: